MedTrace Logo

Cabenuva Injection Tracking in CHORUS

NCT04863261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2025-02-25

No results posted yet for this study

Summary

This is a cluster randomized trial in which clinics will be randomized to the intervention or the control arm. The purpose of this study is to assess if receiving alerts can help providers manage the scheduling of monthly cabotegravir + rilpivirine long-acting injections for the treatment of HIV.

Conditions

  • HIV Infections

Interventions

OTHER

Cabenuva Scheduling Alerts in the Retention & Huddle modules of the CHORUS App

The CHORUS App has been developed as a tool for clinicians to easily visualize important patient information from their smart phones. Relevant information is electronically distributed and placed within the corresponding module in the CHORUS HCP mobile app for iOS and Android.

Sponsors & Collaborators

  • AIDS Healthcare Foundation

    collaborator OTHER

  • ViiV Healthcare

    collaborator INDUSTRY

  • Epividian

    lead INDUSTRY

Principal Investigators

  • Michael Wohlfeiler, MD · AHF

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-07-07
Completion
2022-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863261 on ClinicalTrials.gov